---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-104240"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T12:31:36.167719+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Nektar completes sale of Huntsville manufacturing facility to Ampersand affiliate

## Summary
- Closed disposition of Huntsville, AL manufacturing facility and related assets to an affiliate of Ampersand Capital Partners.
- Transaction completed on December 2, 2024, as previously announced on November 4, 2024.
- Purchaser assumed certain related liabilities; no financial terms disclosed in the filing.

## SEC filing metadata
- accession: 0001213900-24-104240
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390024104240/0001213900-24-104240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390024104240/ea0222533-8k_nektar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-104240
- JSON: https://secwatch.observer/filing/0001213900-24-104240.json
- Plain text: https://secwatch.observer/filing/0001213900-24-104240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.